About this trial
The aim of this study is to evaluate the effect of single versus multiple application protocols for in-office dental bleaching using two different bleaching gels (Pola Office Plus, SDI, 37.5% HP and Opalescence Boost, Ultradent, 40% HP) on the risk and intensity of tooth sensitivity, as well as the effect of the application protocol on the bleaching efficacy.
Null hypothesis: There is no difference in intensity and risk of tooth sensitivity between single and multiple application of each gel and the application protocol dose not present significant effect on the bleaching efficacy.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
At least eight maxillary anterior teeth present.
Age over 18
The selected teeth have a mean shade of C2 or darker.
Good general and oral health. (no visible plaque or gingivitis)
Disqualifiers
Active caries and/or periodontal diseases (gingivitis and recession) or wasting diseases
Smokers
Pregnant/lactating women.
Patients who have bleached their teeth previously.
Trial design
Parallel
Treatments tested in this trial
Opalescence XTra Boost 40% HP
Other interventionIn-office tooth bleaching material
Pola Office Plus 37.5% HP
Other interventionIn-office tooth bleaching material
Treatment groups
Trial outcomes
Primary outcomes
Tooth Sensitivity
Assessing reported tooth sensitivity by two scales.The VAS is a horizontal line with ten digits on it, ranging from 0 to 10, where 0 denotes no pain and 10 represents the worst possible suffering. The participants will be asked to identify their level of pain by marking the corresponding number. The NRS scale comprises scores to denote the intensity of pain (0 = none, 1 = mild, 2 = moderate, 3 = considerable, and 4 = intense).
Secondary outcomes
Change in teeth color
Assessing the change in tooth color by two ways. Subjectively using the VITA classical shade guide and Vita Bleached guide and objectively using the VITA easy shade spectrophotometer.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
King Abdullah University Hospital
Lead sponsor
Jordan University of Science and Technology
Collaborator